K
Kim Dalziel
Researcher at University of Melbourne
Publications - 147
Citations - 2665
Kim Dalziel is an academic researcher from University of Melbourne. The author has contributed to research in topics: Medicine & Cost effectiveness. The author has an hindex of 25, co-authored 109 publications receiving 2151 citations. Previous affiliations of Kim Dalziel include Monash University, Clayton campus & University of Exeter.
Papers
More filters
Journal ArticleDOI
Nasal High-Flow Therapy for Primary Respiratory Support in Preterm Infants
Calum T. Roberts,Calum T. Roberts,Louise S Owen,Brett J. Manley,Dag Helge Frøisland,Susan Donath,Kim Dalziel,Margo Pritchard,David Cartwright,Clare L. Collins,Atul Malhotra,Peter G Davis +11 more
TL;DR: When used as primary support for preterm infants with respiratory distress, high-flow therapy resulted in a significantly higher rate of treatment failure than did CPAP.
Journal ArticleDOI
Systematic review of endoscopic sinus surgery for nasal polyps.
TL;DR: The majority of studies report that symptoms improve following FESS with relatively few complications; however, only a small proportion of evidence is comparative.
Journal ArticleDOI
Endoscopic sinus surgery for the excision of nasal polyps: A systematic review of safety and effectiveness.
TL;DR: Wide variation in complication rates suggests the need for audit of existing practice and additional high-quality studies with a fuller description of potential confounding factors and effect modifiers will help to define the effectiveness of FESS more clearly.
Journal ArticleDOI
Effectiveness and cost-effectiveness of imatinib for first-line treatment of chronic myeloid leukaemia in chronic phase: a systematic review and economic analysis.
TL;DR: Imatinib appears to be more effective than current standard drug treatments in terms of cytogenetic response and progression-free survival, with fewer side-effects, however, there is uncertainty concerning longer term outcomes.
Journal ArticleDOI
The Fontan epidemic: Population projections from the Australia and New Zealand Fontan Registry
Chris Schilling,Kim Dalziel,Russell Nunn,Karin du Plessis,William Y. Shi,David S. Celermajer,David S. Celermajer,David S. Winlaw,Robert G. Weintraub,L. Grigg,Dorothy J. Radford,Andrew Bullock,Thomas L. Gentles,Gavin R. Wheaton,Tim Hornung,Robert N. Justo,Yves d'Udekem,Yves d'Udekem +17 more
TL;DR: The Australian and New Zealand population of patients alive after a Fontan procedure will double over the next 20years increasing the demand for heart-failure services and cardiac transplantation.